Results 201 to 210 of about 351,966 (398)

PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity. [PDF]

J Immunother Cancer, 2023
Koller P, Baran N, Harutyunyan K, Cavazos A, Mallampati S, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X, Curran MA, Hung MC, Konopleva M.   +14 more
europepmc   +1 more source

Interferon Alfa in the treatment of B-cell chronic lymphocytic leukemia [PDF]

, 1994
Adolf, D., Bergmann, L., Dietzfelbinger, H., Emmerich, B., Knauf, W. U., Langenmayer, Irmgard, Maubach, P. A., Mitrou, P. S., Nerl, C., Thiel, E., Ziegle-Heitbrock, H. W. L.   +10 more
core   +1 more source

Bioactive Phytochemical Compounds in Medicago sativa L. (Alfalfa): A Systematic Review of Biological Properties and Therapeutic Relevance in Nutraceutical and Functional Food Implications

Food Frontiers, EarlyView.
ABSTRACT Medicago sativa L. (alfalfa) harbors a remarkably diverse reservoir of bioactive secondary metabolites. Flavonoids, isoflavones, and triterpenoid saponins dominate its bioactivity landscape, driving potent antioxidant, anti‐inflammatory, antimicrobial, estrogenic, hypolipidemic, and cytotoxic actions through redox modulation, membrane ...
Parham Joolaei Ahranjani, Hamid Rashidi Nodeh, Zahra Esfandiari, Giovanna Ferrentino   +3 more
wiley   +1 more source

Successful Treatment of Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in a Child With Acute Lymphocytic Leukemia. [PDF]

Cureus, 2023
Mosleh S, Rabaia D, Zidan T.
europepmc   +1 more source

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

Cancer, 2013
H. Kantarjian, D. Thomas, J. Jorgensen, P. Kebriaei, E. Jabbour, M. Rytting, S. York, F. Ravandi, Rebecca E. Garris, M. Kwari, S. Faderl, J. Cortes, R. Champlin, S. O'brien   +13 more
semanticscholar   +1 more source

Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx

Head &Neck, EarlyView.
ABSTRACT Background University of Michigan Cancer Center (UMCC) protocol 9520 treated stage III/IV locally advanced squamous cell carcinoma of the larynx (LASCCL) with cisplatin and 5‐fluorouracil to select for definitive therapy based on response.
Zachary Risch, Emily Bellile, Moneb S. Bughrara, Paul L. Swiecicki, Keith Casper, Kelly Malloy, Norman Hogikyan, Matthew Spector, Andrew Shuman, Chaz Stucken, Steven Chinn, Douglas C. Chepeha, Shruti Jolly, Michelle Mierzwa, Carol Bradford, Avraham Eisbruch, Thomas Carey, Mark Prince, Gregory T. Wolf, Francis P. Worden   +19 more
wiley   +1 more source

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia. [PDF]

Pharmaceutics, 2023
Zahariev N, Draganova M, Zagorchev P, Pilicheva B.   +3 more
europepmc   +1 more source

Pegasparaginase-induced hepatotoxicity in patients with acute lymphocytic leukemia in the Saudi population: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Alshehri GH, Alsuhebany N, Alhumaid MM, Alanazi RH, Alsetri AA, Bahakeem S, Aldamegh GA, Alangari DT, Alhubaishi AA, Zghebi SS, Alrajhi AM.   +10 more
europepmc   +1 more source

Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. [PDF]

Leuk Lymphoma, 2023
Parisi R, Cowen EA, Gu S, Dusza S, Pulitzer M, Geyer MB, King AC, Markova A.   +7 more
europepmc   +1 more source

Membrane Markers and 14q+ Acute Lymphocytic Leukemia [PDF]

, 1981
Giulio Rossi, G. Alimena
openalex   +1 more source